Brief: SeaStar Medical Q2 EPS USD -0.91
12/08/2026 21:06
BRIEF-SeaStar Medical Q2 EPS USD -0.91 Aug 12 (Reuters) - SeaStar Medical Q2 net income USD -3.73 million.
- Q2 operating income USD -3.791 million
- Q2 operating expenses USD 4.352 million
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview